AVE0657

DRUG2 trials

Sponsors

Sanofi

Conditions

Cheyne-Stokes RespirationHeart FailureSleep Apnea SyndromesSleep Apnea, Obstructive

Phase 2

Evaluation of the Effect of AVE0657 on Obstructive Sleep Apnea

CompletedNCT00614250

SanofiSleep Apnea, Obstructive

Start: 2008-01-31End: 2009-01-31Updated: 2009-07-20

Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome Patients

TerminatedNCT00694720

SanofiCheyne-Stokes Respiration, Heart Failure, Sleep Apnea Syndromes

Start: 2008-06-30End: 2009-03-31Updated: 2009-05-01